5th International Conference on Pediatrics and Child Health

Pediatric Oncology & Hematology brings together pediatric oncologists, hematologists, hematopathologists, transplant specialists, oncology nurses, researchers, geneticists, and healthcare professionals to discuss advances in childhood cancer and blood disorders. The session focuses on leukemia, lymphoma, solid tumors, precision oncology, immunotherapy, CAR-T cell therapy, stem cell transplantation, supportive care, and survivorship, with emphasis on improving treatment outcomes and quality of life.

Key Discussion Areas

• Childhood Cancers and Hematologic Disorders – leukemia, lymphoma, solid tumors, anemia, bleeding disorders, and advanced disease management.
• Precision Oncology and Immunotherapy – genomic profiling, biomarkers, targeted therapies, CAR-T cell therapy, and personalized treatment.
• Stem Cell Transplantation and Cellular Therapies – hematopoietic stem cell transplantation, cellular therapies, transplant complications, and emerging approaches.
• Survivorship and Supportive Care – late effects, rehabilitation, psychosocial support, palliative care, and pediatric oncology nursing.

Benefits of Attending This Session

Pediatric oncologists, hematologists, researchers, transplant specialists, oncology nurses, geneticists, pathologists, and healthcare professionals can gain insights into emerging cancer therapies and multidisciplinary approaches to pediatric cancer care. The session provides opportunities to present research, discuss challenging cases, explore innovative treatments, and develop collaborations across clinical, academic, pharmaceutical, and biotechnology communities.

Frequently Asked Questions

Q: Can research on CAR-T therapy, pediatric leukemia, genomics, or childhood cancer be submitted to this session?

A: Yes. The session welcomes clinical trials, translational research, genomic studies, immunotherapy research, cellular therapies, case studies, and innovative approaches to pediatric oncology and hematology.

Q: Does the session address the long-term needs of childhood cancer survivors?

A: Yes. Discussions include survivorship care, treatment-related late effects, rehabilitation, psychosocial support, quality of life, palliative care, and long-term follow-up of pediatric cancer survivors.